OM

Opaleye Management Portfolio holdings

AUM $758M
1-Year Est. Return 77.57%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+77.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$239M
AUM Growth
+$38.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1
+$4.64M
2
+$3.29M
3
+$2.9M
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$2.83M
5
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$2.55M

Top Sells

1
+$7.08M
2
+$5.1M
3
+$3.2M
4
GNMX
Aevi Genomic Medicine Inc
GNMX
+$1.99M
5
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$1.96M

Sector Composition

1 Healthcare 91.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.35M 0.98%
+16,500
27
$2.33M 0.97%
125,000
+46,700
28
$2.28M 0.95%
+350,200
29
$2.22M 0.93%
317,200
+276,800
30
$1.92M 0.8%
+10,934
31
$1.76M 0.74%
10,950
+8,435
32
$1.73M 0.72%
1,750
-36
33
– –
0
34
$1.33M 0.56%
6,500
-7,500
35
$1.2M 0.5%
970,000
+410,000
36
$1.09M 0.46%
+40,000
37
$1.03M 0.43%
10,857
-4,857
38
$365K 0.15%
+50,000
39
$212K 0.09%
417
40
– –
-11,000
41
– –
-6,125
42
– –
-230,000
43
– –
-4,000
44
– –
-4,250
45
– –
-550,000
46
– –
-45,000
47
– –
-360,000
48
– –
-10,694
49
– –
-36,500
50
– –
-50,000
1
2
3